Inhaled Treprostinil in Pulmonary Hypertension
Aaron B. Waxman
Brigham and Women s Hospital
Aaron Waxman discusses research into patients with pulmonary hypertension due to interstitial lung disease and the effects of inhaled treprostinil. Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School. Read Study Image courtesy of Aaron Waxman
Transcript
Related Videos
Queen Mary University of London
DNA methylation predicts high-grade cervical neoplasia
University of Bath
Shared Genetic Architecture in Anorexia Nervosa
Imperial College London
Gene therapy for heart failure: The end of the beginning?
